COVID-19 Is a Coronary Artery Disease Risk Equivalent and Exhibits a Genetic Interaction With ABO Blood Type

By sjmartinez • October 10, 2024

Hilser JR, Spencer NJ, Afshari K, Gilliland FD, Hu H, Deb A, Lusis AJ, Wilson Tang WH, Hartiala JA, Hazen SL, Allayee H. COVID-19 Is a Coronary Artery Disease Risk Equivalent and Exhibits a Genetic Interaction With ABO Blood Type. Arterioscler Thromb Vasc Biol. 2024 Oct 9. doi: 10.1161/ATVBAHA.124.321001. Epub ahead of print. PMID: 39381876.

Tags: Cardiology/Epi, covid-19, genetics, major adverse cardiac events, myocardial infarction, Publications, SARS-CoV-2, stroke, Thrombosis

Related Posts

Timeliness of Emergency Care for Intracerebral Hemorrhage Compared With Acute Ischemic Stroke

Royan R, Ikeaba U, Alhanti B, Stamm B, Mac Grory B, Prabhakaran S, Maas MB, Fonarow GC, Messe SR, Mamer LE, Goldstein JN, Saver JL,[...]

Genetically engineering mast cells as effectors for targeted cancer cell cytotoxicity

Han X, Wen D, Fu R, Soto J, Song Y, Wu Y, Wang Z, Lin X, Yu J, Sheng T, Li S, Gu Z, He[...]

Design of Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT-Echo-AI)

Eusuff S, Kim J, Fatima Z, Yalcinkaya D, Sahashi Y, Sandhu A, Nguyen LH, Ambrosy AP, Cheng PP, Chang ST, Go AS, Ahmad FS, Cheung[...]